DNA-BASED ENANTIOSEPARATION
313
5. Qu X, Trent JO, Fokt I, Priebe W, Chaires JB. Allosteric, chiral-selective
drug binding to DNA. Proc Natl Acad Sci U S A 2000; 97: 12032–12037.
6. Ito M, Sakakura A, Miyazawa N, Murata S, Yoshikawa K. Nonspecificity
induces chiral specificity in the folding transition of giant DNA. J Am
Chem Soc 2003; 125: 12714–12715.
The test of Scatchard, the plot of q/Ce as a function of q,
was performed to evaluate the presence of cooperative effects
in drug adsorption (Fig. 6c,d). The nonlinearities of all the
Scatchard plots suggest the presence of cooperative effects
during ofloxacin adsorption.28 It can be concluded that ad-
sorption energies are lowered through the conformational
transition of DNA induced by ofloxacin binding (the local dis-
tortions as shown in Fig. 3). Moreover, the maxima of the cur-
vilinear Scatchard plot is determined as 0.075 μmol/mg for
ML DNA, and this q value shifts to 0.20 μmol/mg at the
[Cu2+]/[base] ratio of 0.1. This suggests an increase of bind-
ing cooperativity and a change of adsorption mechanism upon
Cu(II)-coordination. This change is an indication of Cu(II)-in-
duced variations in the relative contribution of electrostatic,
coordination interactions as well as other weak strengths such
as hydrophobic and/or stacking interactions in the adsorption
of ofloxacin on DNA. The studies on the adsorption behavior
not only reveal the adsorption mechanism of ofloxacin enan-
tiomers on natural polynucleotides, but provide fundamental
data to develop novel enantioseparation methods.
7. Zinchenko AA, Sergeyev VG, Kabanov VA, Murata S, Yoshikawa K.
Stereoisomeric discrimination in DNA compaction. Angew Chem Int Ed
2004;43:2378ꢀ2381.
8. Zhang HY, Liu YR, Ji C, Li W, Dou SX, Xie P, Wang WC, Zhang LY, Wang
PY. Oxaliplatin and its enantiomer induce different condensation dynam-
ics of single DNA molecules. PLoS One 2013;8:e71556.
9. Matsuoka Y, Kanda N, Lee YM, Higuchi A. Chiral separation of phenylal-
anine in ultrafiltration through DNA-immobilized chitosan membranes. J
Mem Sci 2006; 280: 116–123.
10. Lee EJ, Yeo JA, Jung K, Hwangbo HJ, Lee GJ, Kim SK. Enantioselective bind-
ing of ofloxacin to B form DNA. Arch Biochem Biophys 2001; 395: 21–24.
11. Hwangbo HJ, Yun BH, Cha JS, Kwon DY, Kima SK. Enantioselective bind-
ing of S- and R-ofloxacin to various synthetic polynucleotides. Eur J Pharm
Sci 2003; 18: 197–203.
12. Hayakawa I, Atarashi S, Yokohama S, Imamura M, Sakano K, Furukawa
M. Synthesis and antibacterial activities of optically active ofloxacin.
Antimicrob Agents Chemother 1986; 29: 163–164.
13. Drew RH, Gallis HA. Ofloxacin: its pharmacology, pharmacokinetics, and
potential for clinical application. Pharmacotherapy 1988; 8: 35–46.
CONCLUSION
14. Fu Y, Duan X, Chen X, Zhang J, Li W. Enantioselective separation of chiral
ofloxacin using functional Cu(II)-coordinated G-rich oligonucleotides.
RSC Adv 2014; 4: 1329–1333.
Natural polynucleotides including Micrococcus lysodeikticus
DNA and calf thymus DNA were used to study the Cu2+-
regulated chiral discrimination of ofloxacin enantiomers.
Both ML and CT DNA exhibit enantioselective recognition
for S-ofloxacin in the presence of Cu2+. Interestingly,
ofloxacin and Cu2+ have cooperative effects on the local
distortions of polynucleotides. In the presence of Cu2+,
S-ofloxacin is more liable to induce the locally distorted struc-
tures of polynucleotides compared to its R-enantiomer, and
these observed structures are recognized as an important
feature of the effects of ofloxacin on the folding transition of
polynucleotides. The association constant of DNA-Cu(II) with
S-ofloxacin is three times higher than that of R-enantiomer.
This binding is a strong enthalpy-driven process accompa-
nied by an unfavorable entropy contribution, which results
from the conformational transition from the elongated coil
to the locally distorted state induced by the partial intercala-
tion of S-ofloxacin. The apparent increase of adsorption capa-
bility and cooperativity, as well as the change of adsorption
mechanism, were detected in the adsorption of ofloxacin en-
antiomers on polynucleotides upon Cu(II)-coordination.
15. Fu Y, Duan X, Chen X, Zhang H, Zhang J, Li W. Chiral discrimination of
ofloxacin enantiomers using DNA double helix regulated by metal ions.
Chirality 2014; 26: 249–254.
16. Li W, Chen X, Fu Y, Zhang J. Enantioselective recognition mechanism of
ofloxacin via Cu(II)-modulated DNA. J Phys Chem B 2014;118:5300ꢀ5309.
17. Tian ML, Row HS, Row KH. Chiral separation of ofloxacin enantiomers by
ligand exchange chromatography. Monatsh Chem 2010; 141: 285–290.
18. Hou XM, Zhang XH, Wei KJ, Ji C, Dou SX, Wang WC, Li M, Wang PY.
Cisplatin induces loop structures and condensation of single DNA mole-
cules. Nucleic Acids Res 2009; 37: 1400–1410.
19. Gossens C, Tavernelli I, Rothlisberger U. DNA structural distortions in-
duced by ruthenium-arene anticancer compounds. J Am Chem So 2008;
130: 10921–10928.
20. Liu Z, Tan S, Zu Y, Fu Y, Meng R, Xing Z. The interactions of cisplatin and
DNA studied by atomic force microscopy. Micron 2010; 41: 833–839.
21. Rai P, Wemmer DE, Linn S. Preferential binding and structural distortion
by Fe2+ at RGGG-containing DNA sequences correlates with enhanced ox-
idative cleavage at such sequences. Nucleic Acids Res 2005; 33: 497–510.
22. Zhou T, Llizo A, Wang C, Xu G, Yang Y. DNA compaction: fundamentals
and applications. Soft Matter 2011; 7: 6746–6756.
23. Lin PH, Tong SJ, Louis SR, Chan Y, Chen WY. Thermodynamic basis of
chiral recognition in a DNA aptamer. Phys Chem Chem Phys 2009; 11:
9744–9750.
24. Bishop GR, Ren JS, Polander BC, Jeanfreau BD, Trent JO, Chaires JB. En-
ergetic basis of molecular recognition in a DNA aptamer. Biophys Chem
2007; 126: 165–175.
25. Zhao C, Ren J, Gregoliński J, Lisowski J, Qu X. Contrasting enantioselective
DNA preference: chiral helical macrocyclic lanthanide complex binding to
DNA. Nucleic Acids Res 2012; 40: 8186–8196.
26. Rodriguez-Ruiz I, Delgado-Lopez JM, Duran-Olivencia MA, Iafisco M,
Tampieri A, Colangelo D, Prat M, Gomez-Morales J. pH-responsive deliv-
ery of doxorubicin from citrate-apatite nanocrystals with tailored carbon-
ate content. Langmuir 2013; 29: 8213–8221.
SUPPORTING INFORMATION
Additional supporting information may be found in the
online version of this article at the publisher’s web-site.
LITERATURE CITED
1. Liu B, Han L, Che S. Formation of enantiomeric impeller-like helical archi-
tectures by DNA self-assembly and silica mineralization. Angew Chem Int
Ed 2012; 51: 923–927.
2. Roelfes G, Feringa BL. DNA-based asymmetric catalysis. Angew Chem
Int Ed 2005; 44: 3230–3232.
3. Zhang L, Song M, Tian Q, Min S. Chiral separation of l,d-tyrosine and l,d-
27. Iafisco M, Di Foggia M, Bonora S, Prat M, Roveri N. Adsorption and spec-
troscopic characterization of lactoferrin on hydroxyapatite nanocrystals.
Dalton Trans 2011; 40: 820–827.
tryptophan by ct DNA. Sep Purif Technol 2007; 55: 388–391.
4. Li W, Li Y, Fu Y, Zhang J. Enantioseparation of chiral ofloxacin using
biomacromolecules. Korean J Chem Eng 2013; 30: 1448–1453.
28. Sharma S, Agarwal GP. Interactions of proteins with immobilized metal
ions — Role of ionic strength and pH. J Colloid Interface Sci 2001; 243:
61–72.
Chirality DOI 10.1002/chir